JP2017510567A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017510567A5 JP2017510567A5 JP2016555690A JP2016555690A JP2017510567A5 JP 2017510567 A5 JP2017510567 A5 JP 2017510567A5 JP 2016555690 A JP2016555690 A JP 2016555690A JP 2016555690 A JP2016555690 A JP 2016555690A JP 2017510567 A5 JP2017510567 A5 JP 2017510567A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- seq
- mcam
- amino acid
- chain variable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461952116P | 2014-03-12 | 2014-03-12 | |
| US61/952,116 | 2014-03-12 | ||
| US201461952833P | 2014-03-13 | 2014-03-13 | |
| US61/952,833 | 2014-03-13 | ||
| US201462023724P | 2014-07-11 | 2014-07-11 | |
| US62/023,724 | 2014-07-11 | ||
| US201462068419P | 2014-10-24 | 2014-10-24 | |
| US62/068,419 | 2014-10-24 | ||
| PCT/IB2015/051787 WO2015136470A1 (en) | 2014-03-12 | 2015-03-12 | Anti-mcam antibodies and associated methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017510567A JP2017510567A (ja) | 2017-04-13 |
| JP2017510567A5 true JP2017510567A5 (enExample) | 2018-03-29 |
Family
ID=52823724
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016555690A Pending JP2017510567A (ja) | 2014-03-12 | 2015-03-12 | 抗ｍｃａｍ抗体および関連の使用方法 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20150259419A1 (enExample) |
| EP (1) | EP3116912A1 (enExample) |
| JP (1) | JP2017510567A (enExample) |
| KR (1) | KR20160131061A (enExample) |
| CN (1) | CN106132990A (enExample) |
| AU (1) | AU2015228454A1 (enExample) |
| BR (1) | BR112016020871A2 (enExample) |
| CA (1) | CA2942233A1 (enExample) |
| CL (1) | CL2016002257A1 (enExample) |
| CU (1) | CU20160133A7 (enExample) |
| EA (1) | EA201691836A1 (enExample) |
| IL (1) | IL247754A0 (enExample) |
| MX (1) | MX2016011731A (enExample) |
| PE (1) | PE20161210A1 (enExample) |
| PH (1) | PH12016501760A1 (enExample) |
| SG (1) | SG11201606274XA (enExample) |
| TW (1) | TW201623331A (enExample) |
| WO (1) | WO2015136470A1 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201922795A (zh) | 2012-09-10 | 2019-06-16 | 愛爾蘭商尼歐托普生物科學公司 | 抗ｍｃａｍ抗體及相關使用方法 |
| US10059761B2 (en) | 2014-03-12 | 2018-08-28 | Prothena Biosciences Limited | Anti-Laminin4 antibodies specific for LG4-5 |
| CA2938946A1 (en) | 2014-03-12 | 2015-09-17 | Prothena Biosciences Limited | Anti-mcam antibodies and associated methods of use |
| JP2018530540A (ja) | 2015-09-16 | 2018-10-18 | プロセナ バイオサイエンシーズ リミテッド | 巨細胞動脈炎、リウマチ性多発筋痛症又は高安動脈炎の処置又は予防のための抗ｍｃａｍ抗体の使用 |
| WO2017075173A2 (en) * | 2015-10-30 | 2017-05-04 | Genentech, Inc. | Anti-factor d antibodies and conjugates |
| WO2017149513A1 (en) | 2016-03-03 | 2017-09-08 | Prothena Biosciences Limited | Anti-mcam antibodies and associated methods of use |
| WO2017208210A1 (en) | 2016-06-03 | 2017-12-07 | Prothena Biosciences Limited | Anti-mcam antibodies and associated methods of use |
| EP3563863B1 (en) * | 2016-12-28 | 2023-07-12 | JCR Pharmaceuticals Co., Ltd. | Lyophilized preparation |
| CR20210435A (es) | 2019-02-18 | 2021-09-20 | Lilly Co Eli | Formulación de anticuerpos terapéuticos |
| WO2022133169A1 (en) | 2020-12-18 | 2022-06-23 | Century Therapeutics, Inc. | Chimeric antigen receptor systems with adaptable receptor specificity |
| US20250082777A1 (en) | 2022-01-10 | 2025-03-13 | Sana Biotechnology, Inc. | Methods of ex vivo dosing and administration of lipid particles or viral vectors and related systems and uses |
| WO2024081820A1 (en) | 2022-10-13 | 2024-04-18 | Sana Biotechnology, Inc. | Viral particles targeting hematopoietic stem cells |
| WO2024119157A1 (en) | 2022-12-02 | 2024-06-06 | Sana Biotechnology, Inc. | Lipid particles with cofusogens and methods of producing and using the same |
| CN121263449A (zh) | 2023-03-21 | 2026-01-02 | 拜格拉夫55公司 | Cd19/cd38多特异性抗体 |
| AU2024274792A1 (en) | 2023-05-23 | 2025-10-23 | Sana Biotechnology, Inc. | Tandem fusogens and related lipid particles |
| CN117069848B (zh) * | 2023-08-02 | 2025-02-28 | 武汉爱博泰克生物科技有限公司 | 抗人cd146兔单克隆抗体及其应用 |
| WO2025184529A1 (en) | 2024-03-01 | 2025-09-04 | Sana Biotechnology, Inc. | Viral particles with fusogen display and related compositions and methods |
| CN119192349A (zh) * | 2024-07-18 | 2024-12-27 | 北京市延庆区疾病预防控制中心 | 用于检测黄连素抗性病毒的试剂及方法 |
Family Cites Families (58)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH652145A5 (de) | 1982-01-22 | 1985-10-31 | Sandoz Ag | Verfahren zur in vitro-herstellung von hybridomen welche humane monoklonale antikoerper erzeugen. |
| US4634666A (en) | 1984-01-06 | 1987-01-06 | The Board Of Trustees Of The Leland Stanford Junior University | Human-murine hybridoma fusion partner |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| DE3883899T3 (de) | 1987-03-18 | 1999-04-22 | Sb2, Inc., Danville, Calif. | Geänderte antikörper. |
| US5057540A (en) | 1987-05-29 | 1991-10-15 | Cambridge Biotech Corporation | Saponin adjuvant |
| US4912094B1 (en) | 1988-06-29 | 1994-02-15 | Ribi Immunochem Research Inc. | Modified lipopolysaccharides and process of preparation |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US5859205A (en) | 1989-12-21 | 1999-01-12 | Celltech Limited | Humanised antibodies |
| EP1690935A3 (en) | 1990-01-12 | 2008-07-30 | Abgenix, Inc. | Generation of xenogeneic antibodies |
| US5427908A (en) | 1990-05-01 | 1995-06-27 | Affymax Technologies N.V. | Recombinant library screening methods |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| US5814318A (en) | 1990-08-29 | 1998-09-29 | Genpharm International Inc. | Transgenic non-human animals for producing heterologous antibodies |
| US5770429A (en) | 1990-08-29 | 1998-06-23 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| US5633425A (en) | 1990-08-29 | 1997-05-27 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| US5625126A (en) | 1990-08-29 | 1997-04-29 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
| US5877397A (en) | 1990-08-29 | 1999-03-02 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
| US5661016A (en) | 1990-08-29 | 1997-08-26 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
| US5874299A (en) | 1990-08-29 | 1999-02-23 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| US5789650A (en) | 1990-08-29 | 1998-08-04 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
| US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
| DK0546073T3 (da) | 1990-08-29 | 1998-02-02 | Genpharm Int | Frembringelse og anvendelse af transgene, ikke-humane dyr, der er i stand til at danne heterologe antistoffer |
| US5194594A (en) | 1990-09-07 | 1993-03-16 | Techniclone, Inc. | Modified antibodies |
| DE69230142T2 (de) | 1991-05-15 | 2000-03-09 | Cambridge Antibody Technology Ltd. | Verfahren zur herstellung von spezifischen bindungspaargliedern |
| US5858657A (en) | 1992-05-15 | 1999-01-12 | Medical Research Council | Methods for producing members of specific binding pairs |
| AU675916B2 (en) | 1991-06-14 | 1997-02-27 | Genentech Inc. | Method for making humanized antibodies |
| ES2136092T3 (es) | 1991-09-23 | 1999-11-16 | Medical Res Council | Procedimientos para la produccion de anticuerpos humanizados. |
| EP0746609A4 (en) | 1991-12-17 | 1997-12-17 | Genpharm Int | NON-HUMAN TRANSGENIC ANIMALS CAPABLE OF PRODUCING HETEROLOGOUS ANTIBODIES |
| US5733743A (en) | 1992-03-24 | 1998-03-31 | Cambridge Antibody Technology Limited | Methods for producing members of specific binding pairs |
| DK0672142T3 (da) | 1992-12-04 | 2001-06-18 | Medical Res Council | Multivalente og multispecifikke bindingsproteiner samt fremstilling og anvendelse af disse |
| US5877218A (en) | 1994-01-10 | 1999-03-02 | Teva Pharmaceutical Industries, Ltd. | Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives |
| US5786464C1 (en) | 1994-09-19 | 2012-04-24 | Gen Hospital Corp | Overexpression of mammalian and viral proteins |
| DE19539493A1 (de) | 1995-10-24 | 1997-04-30 | Thomae Gmbh Dr K | Starker homologer Promotor aus Hamster |
| US5834597A (en) | 1996-05-20 | 1998-11-10 | Protein Design Labs, Inc. | Mutated nonactivating IgG2 domains and anti CD3 antibodies incorporating the same |
| US6114148C1 (en) | 1996-09-20 | 2012-05-01 | Gen Hospital Corp | High level expression of proteins |
| AU753688B2 (en) | 1997-03-10 | 2002-10-24 | Ottawa Civic Loeb Research Institute | Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant |
| US5888809A (en) | 1997-05-01 | 1999-03-30 | Icos Corporation | Hamster EF-1α transcriptional regulatory DNA |
| JP2002536750A (ja) | 1999-02-05 | 2002-10-29 | サムスン エレクトロニクス カンパニー リミテッド | 映像テキスチャー抽出方法及びその装置 |
| CN1671416B (zh) | 2001-07-12 | 2013-01-02 | 杰斐逊·富特 | 超人源化抗体 |
| JP4317010B2 (ja) * | 2001-07-25 | 2009-08-19 | ピーディーエル バイオファーマ，インコーポレイティド | ＩｇＧ抗体の安定な凍結乾燥医薬製剤 |
| JP2005516965A (ja) | 2001-12-28 | 2005-06-09 | アブジェニックス・インコーポレーテッド | 抗ｍｕｃ１８抗体を使用する方法 |
| DE60220719T2 (de) | 2001-12-28 | 2008-03-06 | Amgen Fremont Inc. | Antikörper gegen das muc18-antigen |
| ATE394121T1 (de) | 2001-12-28 | 2008-05-15 | Amgen Fremont Inc | Verwendung von antikörpern gegen das muc18- antigen |
| JP4498746B2 (ja) * | 2002-02-14 | 2010-07-07 | イミューノメディクス、インコーポレイテッド | 抗ｃｄ２０抗体およびその融合タンパク質ならびに使用法 |
| EP1382615A1 (en) * | 2002-07-15 | 2004-01-21 | Xerion Pharmaceuticals AG | MCAM inhibitors |
| BR0316525A (pt) | 2002-11-29 | 2005-10-04 | Boehringer Ingelheim Pharma | Genes de fosfotransferase de neomicina e processos para seleção de células recombinantes de alta produtividade |
| DE10338531A1 (de) | 2003-08-19 | 2005-04-07 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verfahren zur Reklonierung von Produktionszellen |
| BRPI0513714A (pt) * | 2004-07-20 | 2008-05-13 | Symphogen As | procedimento para caracterização estrutural de uma proteìna policlonal recombinante ou uma linhagem de célula policlonal |
| WO2006051065A2 (en) | 2004-11-10 | 2006-05-18 | Boehringer Ingelheim Pharma Gmbh & Co.Kg | Use of flow-cytometric analysis to optimize cell banking strategies for cho cells |
| US20080124760A1 (en) | 2006-07-26 | 2008-05-29 | Barbara Enenkel | Regulatory Nucleic Acid Elements |
| US8455622B2 (en) | 2006-12-01 | 2013-06-04 | Seattle Genetics, Inc. | Variant target binding agents and uses thereof |
| PT2126093E (pt) | 2007-03-02 | 2012-12-03 | Boehringer Ingelheim Pharma | Melhoramento da produção de proteínas |
| EP2031064A1 (de) | 2007-08-29 | 2009-03-04 | Boehringer Ingelheim Pharma GmbH & Co. KG | Verfahren zur Steigerung von Proteintitern |
| KR20120104542A (ko) * | 2009-10-15 | 2012-09-21 | 아보트 러보러터리즈 | Ｉｌ?１ 결합 단백질 |
| TWI513466B (zh) * | 2010-01-20 | 2015-12-21 | Boehringer Ingelheim Int | 抗凝血劑解毒劑 |
| US8974782B2 (en) * | 2011-02-07 | 2015-03-10 | Glaxo Group Limited | Treatment of stroke comprising anti-MAG antibodies |
| JP6305919B2 (ja) * | 2011-06-06 | 2018-04-04 | プロセナ バイオサイエンシーズ リミテッド | Ｍｃａｍアンタゴニスト及び治療の方法 |
| WO2013083497A1 (en) * | 2011-12-06 | 2013-06-13 | F. Hoffmann-La Roche Ag | Antibody formulation |
| TW201922795A (zh) * | 2012-09-10 | 2019-06-16 | 愛爾蘭商尼歐托普生物科學公司 | 抗ｍｃａｍ抗體及相關使用方法 |
-
2015
- 2015-03-10 TW TW104107585A patent/TW201623331A/zh unknown
- 2015-03-12 CN CN201580013418.9A patent/CN106132990A/zh active Pending
- 2015-03-12 KR KR1020167027673A patent/KR20160131061A/ko not_active Withdrawn
- 2015-03-12 WO PCT/IB2015/051787 patent/WO2015136470A1/en not_active Ceased
- 2015-03-12 PE PE2016001594A patent/PE20161210A1/es not_active Application Discontinuation
- 2015-03-12 EP EP15712430.6A patent/EP3116912A1/en not_active Withdrawn
- 2015-03-12 EA EA201691836A patent/EA201691836A1/ru unknown
- 2015-03-12 MX MX2016011731A patent/MX2016011731A/es unknown
- 2015-03-12 BR BR112016020871A patent/BR112016020871A2/pt not_active Application Discontinuation
- 2015-03-12 US US14/656,596 patent/US20150259419A1/en not_active Abandoned
- 2015-03-12 SG SG11201606274XA patent/SG11201606274XA/en unknown
- 2015-03-12 AU AU2015228454A patent/AU2015228454A1/en not_active Abandoned
- 2015-03-12 CA CA2942233A patent/CA2942233A1/en not_active Abandoned
- 2015-03-12 JP JP2016555690A patent/JP2017510567A/ja active Pending
-
2016
- 2016-09-07 CL CL2016002257A patent/CL2016002257A1/es unknown
- 2016-09-07 PH PH12016501760A patent/PH12016501760A1/en unknown
- 2016-09-11 IL IL247754A patent/IL247754A0/en unknown
- 2016-09-12 CU CUP2016000133A patent/CU20160133A7/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017510567A5 (enExample) | ||
| CN107353342B (zh) | PDGF受体β结合多肽 | |
| JP2017518258A5 (enExample) | ||
| KR102473544B1 (ko) | 항체-fynomer 접합체 | |
| US20190169289A1 (en) | Optimized pne-based chimeric receptor t cell switches and uses thereof | |
| JP7460819B2 (ja) | ヒト抗セマフォリン４ｄ抗体 | |
| JP2018521691A5 (enExample) | ||
| HRP20150799T1 (hr) | Sastavi i postupci za protutijela protiv komplementnog proteina c5 | |
| HRP20161656T4 (hr) | Sredstva za vezanje na cd33 | |
| JP2014221758A5 (enExample) | ||
| JP2018502060A5 (enExample) | ||
| RU2018106364A (ru) | Антитела против рецептора tfr и их применение при лечении пролиферативных и воспалительных расстройств | |
| WO2016191643A4 (en) | Tigit-binding agents and uses thereof | |
| JP2015535691A5 (enExample) | ||
| HRP20192285T1 (hr) | Anti-ox40 protutijela i postupci uporabe | |
| HK1254289A1 (zh) | 调控免疫反应的方法及抗体 | |
| ES2909720T3 (es) | Terapia de combinación con un anticuerpo anti-CD19 y un análogo de purina | |
| HRP20240719T1 (hr) | Kimerna i humanizirana monoklonska protutijela protiv ljudskog ctla4 i njihova upotreba | |
| JP2020513791A5 (enExample) | ||
| JP2020513809A5 (enExample) | ||
| JP2019510739A5 (enExample) | ||
| WO2015057834A1 (en) | Peptidic chimeric antigen receptor t cell switches and uses thereof | |
| JP2017523786A5 (enExample) | ||
| JP2016512551A5 (enExample) | ||
| HRP20200881T1 (hr) | Antitijela koja vežu beta-klotho domenu 2 i postupci njihove uporabe |